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in a patient with a coincidental diagnosis of
breast cancer: a case report
Maddalena Borriello1, Alessandro Lucidi1,2, Arnaldo Carbone3, Vito Iannone1 and Gabriella Ferrandina2*Abstract: Madelung’s disease or multiple symmetric lipomatosis (MSL) is a rare disorder of unknown etiology which
typically presents symmetrically subcutaneous accumulation of non-encapsulated adipose tissue which slowly
grows around the neck, upper part of the arms, pelvis, back and thigh. This disease is also frequently associated
with hepatopathy, glucose intolerance, hyperuricemia, and malignant tumors of the upper airways. Nevertheless,
only one description of malignant transformation of Madelung’s disease has been presented in literature. Here, we
report a case of liposarcomatous transformation of Madelung’s disease in a 59-year-old Italian woman with a
coincidental diagnosis of breast cancer.
Virtual slide: The virtual slide for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
3480884087499351
Keywords: Madelung disease, Malignant degeneration, Breast cancerBackground
Multiple symmetric lipomatosis (MSL) also known as
Madelung disease or Launois-Bensaude syndrome is a
rare disorder of unknown etiology first described in
1846 by Brodie and in 1888 by Madelung [1]. MSL
mostly occurs in Mediterranean middle-age male (30–
60 years old) with a history of chronic alcoholism [2].
Typical features of this condition are due to symmetric
subcutaneous accumulation of non-encapsulated adipose
tissue, which slowly grows around the neck, upper part
of the arms, pelvis, back and thigh. Enzi et al. [2]
described two types of lipomatosis based on the distribu-
tion of fat tissue: type I is characterized by lipomas
located in the nape of the neck, the supraclavicular and
deltoid regions (Madelung’s collar), while in Type II
lipomatosis, fat tissue diffuses extensively in to the sub-
cutaneous fat layer giving the patient and appearance of
simple obesity. Besides the disfiguring aesthetic effects,
in some cases lipomatous masses can infiltrate spaces
between adjacent structures, thus leading to signs/symp-
toms of compression/infiltration of the upper aerodiges-
tive tract (dyspnea, dysphonia, dysphagia), low mobility* Correspondence: gabriella.ferrandina@libero.it
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syndrome etc.
The exact pathogenesis is unclear although several the-
ories have been proposed: in particular, enzymatic defects
of lipid metabolism (especially for catecholamine-induced
lipolysis) and, more recently, the occurrence of mutations
of mitochondrial DNA have been involved in the marked
increase of adipose tissue. Moreover, some evidences have
suggested that cellular elements involved in MSL patho-
genesis might be represented by precursors from brown
fat tissues [2,3].
There are no clear guidelines for the overall manage-
ment and treatment of MSL: patients are usually triaged
to surgical removal of large lipomas even though med-
ical treatment aimed at correcting metabolic disorders
are also employed [3,4]. Besides the association with
other pathological conditions such as polyneuropathy
and metabolic disturbancies, Madelung’s disease has
been also related to the occurrence of oro-pharyngeal
tumors [5]; whether these findings are just coincidental
or reflect the increased prevalence of risk factors (i.e. al-
cohol, smoking) in these patients remains unclear [3,5].
On the other hand, only one case of liposarcomatous
progression of Madelung’s disease has been reported in
the literature [6].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Madelung’s disease in a 59-year-old Italian woman with
a coincidental diagnosis of breast cancer.
Case presentation
In October 2011, a 59-year-old woman was referred to
our Institution because of the documentation of a breast
nodule suspicious for malignancy.
Her familial history was unremarkable for neoplasias
and congenital disorders. The patients reported
a >30 year history of alcohol abuse as well as severe
gastro-duodenal ulcer, and recurrent episodes of phle-
bitis of the lower limbs requiring surgery. She also
reported multiple surgeries due to large lipomatous
masses located in the neck, shoulder and upper arms.
She was 147 cm tall and weighted 70 kg (BMI= 32.4).
Physical examination showed an enlargement of the
anterior cervical region, as well as the presence of sym-
metric masses of the upper arms typical of Type I
Madelung’s disease (Figure 1A).
Patient’s haematological and chemical profile was within
normal limits with the exception of elevated serum levels
of aspartate (240 IU/l) and alanine (108 IU/l) aminotrans-
ferase. Bilirubin and γ-glutamyl-trasferase levels were also
above the normal limits (1.33 mg/dl, and 334 IU/l,
respectively).
Needle aspiration cytology of a 2 cm breast nodule of
the left subareolar region was performed, and was sug-
gestive of carcinoma. Staging work-up, including chest
x-rays, US liver examination and PET-CT scan. Ca15-3
and Ca125 levels were within the normal limit.
In November 2011 the patient underwent total left
mastectomy and sentinel lymph node biopsy. Frozen
section analysis was positive for carcinoma both in the
breast and in the sentinel lymph node. Therefore, a cau-
tious axillary lymph node dissection was performed after
a difficult identification of the axillary vein which
appeared intermingled within an apparently lipomatous
mass. Final histology showed invasive breast carcinoma
with a poor grade of differentiation and metastaticA B
Figure 1 Picture of the patient showing Type I MSL with symmetric a
(A) and upper arms (B).lymph node involvement (final stage: pT1cN1M0).
Histopathologic analysis of resected axillary fat tissue
showed a well differentiated liposarcoma with myxoid
aspects. In particular, no signs of flogosis was observed,
while the lipoblasts are characterized by the morphology
of the neoplastic elements with an atypical nucleus
containing a nucleolus, and a cytoplasm with a single,
large lipidic vacuole (Figure 2 A,B). No immunohisto-
chemistry was required for the diagnosis.
A multidisciplinary team including Medical Oncologists
and Internists carefully evaluated the need to administer
adjuvant treatment with the presence of comorbidities: in-
deed, based on stage and grade of breast cancer, the docu-
mentation of positive Ki67 staining in 42% of tumor cells
as well as the concomitant diagnosis of liposarcoma, the
patient was triaged to chemotherapy with single agent
epirubicine followed by hormone treatment.
Conclusions
To our knowledge, this is the second case reported in
the literature of liposarcomatous transformation oc-
curring in a patient affected by Madelung’s disease.
The first description dates back to 1983, when Tizian
et al. [6] reported on a 57-year-old woman with a
7-year history of progressive, symmetric thickening of
the neck due to histologically confirmed benign lipo-
matosis. Changes of clinical appearance of the left
side of neck lipomatosis, which had become smaller,
harder and fixed to the skin, as well as the occur-
rence of dyspnoea and limited mobility of the cervical
spine had accelerated the execution of radiographic
studies which confirmed infiltration of soft tissues,
but failed to document any tumor mass displacing
the trachea. After surgical resection of lipomatous
masses, histopathology had revealed the presence of
areas of myxoid liposarcoma in the context of larger
parts of embrional lipoblasts, and the patient had
been triaged to adjuvant chemotherapy [6].
In our MSL case, the diagnosis of liposarcomatous
progression was documented in the left axillary lipomasccumulation of lipomatous tissue in the anterior cervical region
Figure 2 Malignant transformation of axillary lipomatous
masses in Madelung’s disease. Malignant transformation of axillary
lipomatous masses in Madelung’s disease. A) At low magnification
vascular density was evident with abundance of vessels with
characteristic arborizing shapes (H&E; original magnification: 200x).
B) Lipoblasts were frequently observed at high power magnification
(insets), together with the typical delicate vascular network
(not shown). In the lower right inset an atypical mitosis is shown.
These findings indicated a well differentiated liposarcoma
(H&E; original magnification: 400x).
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cancer: indeed, at clinical examination, no suspicion of
axillary tumor involvement had emerged; moreover, sta-
ging work up with US, mammography, and PET/CT
scan also failed to document any abnormalities. CT and
MRI have been reported to play a relevant role in asses-
sing the extension and distribution of lipomatous masses
[7], however, the difficulties to differentiate benign lip-
omas versus liposarcoma solely on radiological basis are
also acknowledged [8]. Therefore, any modification of
lipomatous masses, especially if asymmetric, and the ap-
pearance of signs/symptoms of compression/infiltration
of aerodigestive tract should be taken into account for
planning surgery which still remains the mainstay of
treatment. A prompt removal of lipomatous masses
confirms histology, increases the chances of a radicalexcision, and could also help to diagnose malignant
airway tumors whose symptoms could go underesti-
mated because attributed to a long standing Madelung’s
disease [5].
On the other hand, in cases refusing surgery or still
considered as not requiring surgical removal of asymp-
tomatic masses, a biopsy could be performed even
though the diagnostic limits inherent in this procedure
should be recognized.
No clear guidelines for the overall management of
Madelung’s disease are available given the rarity of dis-
ease: removal of lipomatous masses by lipectomy, or
US-assisted liposuction in selected cases [9] is strongly
recommended. Recently, also intralesional injections of
phosphatidylcholine (mesotherapy) has been reported as
a potentially effective therapy for MSL [10].
Moreover, regular follow up visits could be advocated
for early diagnosis of aerodigestive tract malignancies or
liposarcomatous transformation. In fact, malignant trans-
formation of lipomas documented by us and Tizian et al.
[6] correspond to 0.6-0.7% of cases with Madelung’s
disease reported in the literature (2 out of approximately
300 cases). A more in-depth analysis of molecular path-
ways associated with MSL would open novel perspectives
in terms of disease management and understanding of
pathogenesis: indeed, MSL adipocytes have been proposed
to originate from the brown adipose tissue precursors
given the similarity of morphological appearance and
expression of specific molecular markers, such as the
mitochondrial inner protein UCP-1 [11]. Moreover, MSL
adipocytes exhibit an increased, so-called tumor-like,
proliferation rate, and have been described as showing
intermediate morphological features between lipoma and
liposarcoma [12]. Whether the mutations of mitochon-
drial DNA described in MSL adipocytes are directly
responsible of the increased growth rate [13] or are just an
epiphenomenon of disturbances of other metabolic path-
ways remains to be established.Consent
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